Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its availability have become key topics for patients and healthcare professionals. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant obstacle